Research ArticleLaboratory Study
Preclinical Evaluation of Technetium-99m-Labeled Somatostatin Receptor-Binding Peptides
Shankar Vallabhajosula, Brian R. Moyer, John Lister-James, Bill J. McBride, Helena Lipszyc, Hiram Lee, Diago Bastidas and Richard T. Dean
Journal of Nuclear Medicine June 1996, 37 (6) 1016-1022;
Shankar Vallabhajosula
Brian R. Moyer
John Lister-James
Bill J. McBride
Helena Lipszyc
Hiram Lee
Diago Bastidas


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Preclinical Evaluation of Technetium-99m-Labeled Somatostatin Receptor-Binding Peptides
Shankar Vallabhajosula, Brian R. Moyer, John Lister-James, Bill J. McBride, Helena Lipszyc, Hiram Lee, Diago Bastidas, Richard T. Dean
Journal of Nuclear Medicine Jun 1996, 37 (6) 1016-1022;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Preclinical Evaluation of a High-Affinity 18F-Trifluoroborate Octreotate Derivative for Somatostatin Receptor Imaging
- Radiopeptide Imaging and Therapy in the United States
- Early Prediction of Endocrine Therapy Effect in Advanced Breast Cancer Patients Using 99mTc-Depreotide Scintigraphy
- MicroPET Imaging of Gene Transfer with a Somatostatin Receptor-Based Reporter Gene and 94mTc-Demotate 1
- 99mTc-Depreotide Chest SPECT Demonstrates Pulmonary Metastases from Renal Cell Carcinoma
- Orbital Scintigraphy with the Somatostatin Receptor Tracer 99mTc-P829 in Patients with Graves' Disease
- An Intrapatient Comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-Octreotide for Diagnosis of Somatostatin Receptor-Expressing Tumors
- Detection of Neuroendocrine Tumors: 99mTc-P829 Scintigraphy Compared with 111In-Pentetreotide Scintigraphy